Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Active hexose correlated compound modulates LPS-induced hypotension and gut injury in rats.

Doursout MF, Liang Y, Sundaresan A, Wakame K, Fujii H, Takanari J, Devakottai S, Kulkarni A.

Int Immunopharmacol. 2016 Oct;39:280-286. doi: 10.1016/j.intimp.2016.07.023. Epub 2016 Aug 5.

PMID:
27500458
2.

Lactoferrin moderates LPS-induced hypotensive response and gut injury in rats.

Doursout MF, Horton H, Hoang L, Liang Y, Hwang SA, Boyd S, Actor JK, Kruzel ML.

Int Immunopharmacol. 2013 Feb;15(2):227-31. doi: 10.1016/j.intimp.2012.12.009. Epub 2012 Dec 23.

PMID:
23267765
3.

Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.

Ignacio RM, Kim CS, Kim YD, Lee HM, Qi XF, Kim SK.

Cytokine. 2015 Dec;76(2):131-137. doi: 10.1016/j.cyto.2015.06.002. Epub 2015 Jun 13.

PMID:
26082022
4.

Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4.

Mallet JF, Graham É, Ritz BW, Homma K, Matar C.

Eur J Nutr. 2016 Feb;55(1):139-46. doi: 10.1007/s00394-015-0832-2. Epub 2015 Jan 18.

PMID:
25596849
5.

CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS.

Molina PE, Qian L, Schuhlein D, Naukam R, Wang H, Tracey KJ, Abumrad NN.

Shock. 1998 Nov;10(5):329-34.

PMID:
9840647
6.

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z.

Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. Epub 2005 Dec 16.

PMID:
16362410
7.

Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Wang S, Welte T, Fang H, Chang GJ, Born WK, O'Brien RL, Sun B, Fujii H, Kosuna K, Wang T.

J Nutr. 2009 Mar;139(3):598-602. doi: 10.3945/jn.108.100297. Epub 2009 Jan 13.

8.

San-Huang-Xie-Xin-Tang reduces lipopolysaccharides-induced hypotension and inflammatory mediators.

Lo YC, Tsai PL, Huang YB, Shen KP, Tsai YH, Wu YC, Lai YH, Chen IJ.

J Ethnopharmacol. 2005 Jan 4;96(1-2):99-106.

PMID:
15588656
9.

N-acetylcysteine abrogates acute lung injury induced by endotoxin.

Kao SJ, Wang D, Lin HI, Chen HI.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):33-40.

PMID:
16445696
10.

A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers.

Spierings EL, Fujii H, Sun B, Walshe T.

J Nutr Sci Vitaminol (Tokyo). 2007 Dec;53(6):536-9.

11.

Hypotension during septic shock does not correlate with exhaled nitric oxide in anesthetized rat.

Pedoto A, Wang J, Tassiopoulos AK, Hakim TS, Yang ZJ, Camporesi EM.

Shock. 2002 May;17(5):427-32.

PMID:
12022766
12.

Effect of active hexose correlated compound on the production of nitric oxide in hepatocytes.

Matsui K, Kawaguchi Y, Ozaki T, Tokuhara K, Tanaka H, Kaibori M, Matsui Y, Kamiyama Y, Wakame K, Miura T, Nishizawa M, Okumura T.

JPEN J Parenter Enteral Nutr. 2007 Sep-Oct;31(5):373-80; discussion 380-1.

PMID:
17712145
13.

Adenosine, a hepato-protective component in active hexose correlated compound: its identification and iNOS suppression mechanism.

Tanaka Y, Ohashi S, Ohtsuki A, Kiyono T, Park EY, Nakamura Y, Sato K, Oishi M, Miki H, Tokuhara K, Matsui K, Kaibori M, Nishizawa M, Okumura T, Kwon AH.

Nitric Oxide. 2014 Aug 31;40:75-86. doi: 10.1016/j.niox.2014.05.007. Epub 2014 May 27.

PMID:
24878381
14.

Active hexose correlated compound inhibits the expression of proinflammatory biomarker iNOS in hepatocytes.

Matsui K, Ozaki T, Oishi M, Tanaka Y, Kaibori M, Nishizawa M, Okumura T, Kwon AH.

Eur Surg Res. 2011;47(4):274-83. doi: 10.1159/000333833. Epub 2011 Nov 10.

PMID:
22076046
15.

Genotoxicity and subchronic toxicity evaluation of Active Hexose Correlated Compound (AHCC).

Fujii H, Nishioka N, Simon RR, Kaur R, Lynch B, Roberts A.

Regul Toxicol Pharmacol. 2011 Mar;59(2):237-50. doi: 10.1016/j.yrtph.2010.10.006. Epub 2010 Oct 14.

PMID:
20951179
16.

Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin.

Kao SJ, Liu DD, Su CF, Chen HI.

J Cardiovasc Pharmacol. 2007 Sep;50(3):333-42.

PMID:
17878764
17.

Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.

Matsushita K, Kuramitsu Y, Ohiro Y, Obara M, Kobayashi M, Li YQ, Hosokawa M.

Anticancer Drugs. 1998 Apr;9(4):343-50.

PMID:
9635925
18.
19.

Short-term supplementation with active hexose correlated compound improves the antibody response to influenza B vaccine.

Roman BE, Beli E, Duriancik DM, Gardner EM.

Nutr Res. 2013 Jan;33(1):12-7. doi: 10.1016/j.nutres.2012.11.001. Epub 2012 Dec 4.

PMID:
23351405
20.

The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.

Sun B, Wakame K, Sato E, Nishioka H, Aruoma OI, Fujii H.

Cancer Epidemiol. 2009 Oct;33(3-4):293-9. doi: 10.1016/j.canep.2009.07.006. Epub 2009 Aug 20.

PMID:
19699163

Supplemental Content

Support Center